A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study

被引：0

作者：

Taiga Otsuka

Tsuyoshi Shirakawa

Mototsugu Shimokawa

Futa Koga

Yasunori Kawaguchi

Yujiro Ueda

Junichi Nakazawa

Azusa Komori

Satoshi Otsu

Shiho Arima

Masaru Fukahori

Yoshinobu Okabe

Akitaka Makiyama

Hiroki Taguchi

Takuya Honda

Taro Shibuki

Kenta Nio

Yasushi Ide

Toshihiko Mizuta

Kenji Mitsugi

Norio Ureshino

机构：

[1] Saga Medical Center Koseikan,Department of Medical Oncology

[2] Minato Medical Clinic,Department of Internal Medicine

[3] Fukuoka Wajiro Hospital,Department of Medical Oncology

[4] Karatsu Higashi-Matsuura Medical Association Center,Clinical Research Institute

[5] National Kyushu Cancer Center,Department of Biostatistics

[6] Yamaguchi University Graduate School of Medicine,Department of Hepatobiliary and Pancreatology

[7] Saga Medical Center Koseikan,Department of Gastroenterology

[8] Asakura Medical Association Hospital,Department of Hematology and Oncology

[9] Japanese Red Cross Kumamoto Hospital,Department of Medical Oncology

[10] Kagoshima City Hospital,Department of Medical Oncology and Hematology

[11] Oita University Faculty of Medicine,Digestive and Lifestyle Diseases

[12] Kagoshima University Graduate School of Medical and Dental Sciences,Department of Internal Medicine, Division of Gastroenterology

[13] Kurume University Hospital,Department of Hematology/Oncology

[14] Japan Community Healthcare Organization Kyushu Hospital,Department of Gastroenterology

[15] Cancer Center,Department of Gastroenterology

[16] Gifu University Hospital,Department of Gastroenterology and Hepatology

[17] Saiseikai Sendai Hospital,Department of Internal Medicine

[18] Izumi General Medical Center,Department of Hepatobiliary and Pancreatic Oncology

[19] Nagasaki University Graduate School of Biomedical Sciences,Department of Medical Oncology

[20] Imari Arita Kyoritsu Hospital,Department of Internal Medicine

[21] Saga,Department of Internal Medicine

[22] National Cancer Center Hospital East,Department of Medical Oncology

[23] Sasebo Kyosai Hospital,Department of Medical Oncology

[24] Karatsu Red Cross Hospital,undefined

[25] Fujikawa Hospital,undefined

[26] Hamanomachi Hospital,undefined

[27] Kimitsu Chuo Hospital,undefined

来源：

International Journal of Clinical Oncology | 2021年 / 26卷

关键词：

Pancreatic cancer; FOLFIRINOX; Gemcitabine; Nab-paclitaxel; Propensity score analysis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：941 / 950

页数：9

共 50 条

[1] A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study
Otsuka, Taiga
Shirakawa, Tsuyoshi
Shimokawa, Mototsugu
Koga, Futa
Kawaguchi, Yasunori
Ueda, Yujiro
Nakazawa, Junichi
Komori, Azusa
Otsu, Satoshi
Arima, Shiho
Fukahori, Masaru
Okabe, Yoshinobu
Makiyama, Akitaka
Taguchi, Hiroki
Honda, Takuya
Shibuki, Taro
Nio, Kenta
Ide, Yasushi
Mizuta, Toshihiko
Mitsugi, Kenji
Ureshino, Norio
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (05) : 941 - 950
[2] Gemcitabine plus nab-paclitaxel vs. FOLFIRINOX for patients with advanced pancreatic cancer
Junko Tahara
Kyoko Shimizu
Nao Otsuka
Junichi Akao
Yukiko Takayama
Katsutoshi Tokushige
Cancer Chemotherapy and Pharmacology, 2018, 82 : 245 - 250
[3] Gemcitabine plus nab-paclitaxel vs. FOLFIRINOX for patients with advanced pancreatic cancer
Tahara, Junko
Shimizu, Kyoko
Otsuka, Nao
Akao, Junichi
Takayama, Yukiko
Tokushige, Katsutoshi
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (02) : 245 - 250
[4] Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study
Williet, Nicolas
Saint, Angelique
Pointet, Anne-Laure
Tougeron, David
Pernot, Simon
Pozet, Astrid
Bechade, Dominique
Trouilloud, Isabelle
Lourenco, Nelson
Hautefeuille, Vincent
Locher, Christophe
Desrame, Jerome
Artru, Pascal
Bidault, Anne Thirot
Le Roy, Bertrand
Pezet, Denis
Phelip, Jean-Marc
Taieb, Julien
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
[5] Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
Han, Sung Yong
Kim, Dong Uk
Seol, Young Mi
Kim, Suk
Lee, Nam Kyung
Hong, Seung Baek
Seo, Hyung-Il
WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (17) : 3718 - 3729
[6] FOLFIRINOX or nab-paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: an observational study
Servetto, Alberto
Santaniello, Antonio
Napolitano, Fabiana
Foschini, Francesca
Marciano, Roberta
Cascetta, Priscilla
Amato, Anna Rita
Augurio, Maria Rosaria
Maresca, Lucia
De Placido, Pietro
De Placido, Sabino
Formisano, Luigi
Bianco, Roberto
FUTURE ONCOLOGY, 2022, 18 (21) : 2643 - 2654
[7] FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study
In Rae Cho
Huapyong Kang
Jung Hyun Jo
Hee Seung Lee
Moon Jae Chung
Jeong Youp Park
Seung Woo Park
Si Young Song
Chansik An
Mi-Suk Park
Seungmin Bang
World Journal of Gastrointestinal Oncology, 2020, 12 (02) : 182 - 194
[8] FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study
Cho, In Rae
Kang, Huapyong
Jo, Jung Hyun
Lee, Hee Seung
Chung, Moon Jae
Park, Jeong Youp
Park, Seung Woo
Song, Si Young
An, Chansik
Park, Mi-Suk
Bang, Seungmin
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (02) : 182 - 194
[9] Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis
Kang, Jihoon
Hwang, Inhwan
Yoo, Changhoon
Kim, Kyu-pyo
Jeong, Jae Ho
Chang, Heung-Moon
Lee, Sang Soo
Park, Do Hyun
Song, Tae Jun
Seo, Dong Wan
Lee, Sung Koo
Kim, Myung-Hwan
Hong, Seung-Mo
Shin, Sang Hyun
Hwang, Dae Wook
Song, Ki Byung
Lee, Jae Hoon
Kim, Song Cheol
Ryoo, Baek-Yeol
INVESTIGATIONAL NEW DRUGS, 2018, 36 (04) : 732 - 741
[10] Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study
Williet, Nicolas
Petrillo, Angelica
Roth, Gael
Ghidini, Michele
Petrova, Mila
Forestier, Julien
Lopez, Anthony
Thoor, Audrey
Weislinger, Lucie
De Vita, Ferdinando
Taieb, Julien
Phelip, Jean Marc
CANCERS, 2021, 13 (11)

← 1 2 3 4 5 →